Silvercrest Asset Management Group LLC Increases Position in Transcat, Inc. (NASDAQ:TRNS)

Silvercrest Asset Management Group LLC increased its stake in Transcat, Inc. (NASDAQ:TRNS) by 4.6% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 58,381 shares of the scientific and technical instruments company’s stock after purchasing an additional 2,542 shares during the quarter. Silvercrest Asset Management Group LLC owned 0.66% of Transcat worth $6,505,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in the stock. Vanguard Group Inc. grew its stake in Transcat by 13.3% in the 3rd quarter. Vanguard Group Inc. now owns 425,378 shares of the scientific and technical instruments company’s stock valued at $41,674,000 after acquiring an additional 49,828 shares during the last quarter. Raymond James & Associates lifted its holdings in shares of Transcat by 6.5% during the 4th quarter. Raymond James & Associates now owns 6,384 shares of the scientific and technical instruments company’s stock worth $698,000 after acquiring an additional 387 shares during the period. Arizona State Retirement System increased its position in Transcat by 11.9% during the 4th quarter. Arizona State Retirement System now owns 2,434 shares of the scientific and technical instruments company’s stock worth $266,000 after purchasing an additional 258 shares in the last quarter. Conestoga Capital Advisors LLC grew its position in Transcat by 0.6% in the fourth quarter. Conestoga Capital Advisors LLC now owns 762,861 shares of the scientific and technical instruments company’s stock valued at $83,404,000 after acquiring an additional 4,805 shares in the last quarter. Finally, Calamos Advisors LLC grew its position in Transcat by 7.3% in the fourth quarter. Calamos Advisors LLC now owns 9,281 shares of the scientific and technical instruments company’s stock valued at $1,015,000 after acquiring an additional 634 shares in the last quarter. Hedge funds and other institutional investors own 98.34% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on TRNS. Northland Capmk downgraded shares of Transcat from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, May 22nd. Oppenheimer increased their price objective on shares of Transcat from $125.00 to $160.00 and gave the company an “outperform” rating in a research report on Wednesday, May 22nd. HC Wainwright reissued a “buy” rating and set a $156.00 price target on shares of Transcat in a research report on Tuesday. Finally, Northland Securities downgraded shares of Transcat from an “outperform” rating to a “market perform” rating in a research report on Wednesday, May 22nd. Three analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $142.67.

Insider Buying and Selling

In other Transcat news, CEO Lee D. Rudow sold 12,000 shares of the firm’s stock in a transaction on Thursday, May 23rd. The stock was sold at an average price of $135.10, for a total value of $1,621,200.00. Following the sale, the chief executive officer now directly owns 91,692 shares in the company, valued at $12,387,589.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, CEO Lee D. Rudow sold 3,343 shares of Transcat stock in a transaction dated Monday, May 20th. The shares were sold at an average price of $124.12, for a total transaction of $414,933.16. Following the sale, the chief executive officer now directly owns 103,692 shares in the company, valued at $12,870,251.04. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Lee D. Rudow sold 12,000 shares of the stock in a transaction dated Thursday, May 23rd. The shares were sold at an average price of $135.10, for a total transaction of $1,621,200.00. Following the completion of the transaction, the chief executive officer now owns 91,692 shares of the company’s stock, valued at approximately $12,387,589.20. The disclosure for this sale can be found here. Insiders have sold 22,215 shares of company stock worth $2,969,084 over the last ninety days. 4.20% of the stock is owned by insiders.

Transcat Stock Down 12.0 %

Shares of TRNS stock traded down $16.21 during mid-day trading on Tuesday, reaching $118.98. 51,254 shares of the company were exchanged, compared to its average volume of 42,173. Transcat, Inc. has a fifty-two week low of $82.60 and a fifty-two week high of $147.12. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.62 and a current ratio of 3.14. The company has a market capitalization of $1.09 billion, a P/E ratio of 85.03 and a beta of 0.68. The business’s 50 day simple moving average is $128.23 and its 200 day simple moving average is $115.64.

Transcat (NASDAQ:TRNS) last announced its quarterly earnings data on Monday, May 20th. The scientific and technical instruments company reported $0.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.52 by $0.25. Transcat had a return on equity of 9.50% and a net margin of 5.26%. The firm had revenue of $70.91 million for the quarter, compared to analysts’ expectations of $68.76 million. Research analysts predict that Transcat, Inc. will post 1.99 earnings per share for the current year.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.